1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Photomedicine: Technologies and Global Markets

Photomedicine: Technologies and Global Markets

  • September 2014
  • -
  • BCC Research
  • -
  • 141 pages

Summary

Table of Contents

This BCC Research study provides a comprehensive analysis of the market of photomedicine. It addresses the drivers and limiters of the market and offers an exhaustive analysis of both drugs and medical devices for use in this industry. The photomedicine global market is analyzed and historical sales of drugs and medical devices used in photomedicine are included for 2013 and estimates provided for 2014. Revenue forecasts are also included through 2019.

Use this report to:
- Understand the pharmaceutical and medical device markets in photomedicine, as well as the need for innovation and new marketing strategies.
- Receive in-depth market analysis, with segmentation by region, by products and type of products, by therapeutic areas and by type of treatment.
- Focus on the drugs activated by light, ultraviolet phototherapy, photodynamic therapy (PDT), and low-level laser light therapy.
- Learn about the major products that generate the largest revenues, as well as the most-valuable R&D products.

Highlights
- The global market of photomedicine, including drugs and devices, was valued at $609.7 million in 2013. The market is expected to reach $616.8 million in 2014 and $754 million in 2019, a compound annual growth rate (CAGR) of 4.1% for the five-year period, 2014 to 2019.
- North America holds the most market share and is expected to increase from $300.9 million in 2014 to $372 million in 2019, a CAGR of 4.3% from 2014 to 2019.
- The European region is expected to reach $198.6 million in 2014 and $238.8 million in 2019, a CAGR of 3.8% from 2014 to 2019.

Introduction & Scope

INTRODUCTION

STUDY GOALS AND OBJECTIVES
This study provides a comprehensive analysis of the market of photomedicine. Photomedicine is comprehensive of both therapeutics activated by light, as well as light emitting medical devices such as UV lamps and some lasers. In particular, this study will focus on drugs activated by light, ultraviolet phototherapy, photodynamic therapy (PDT), and low-level laser light therapy. Surgical lasers will be excluded from this report.

Phototherapy has been used to treat psoriasis for the past 100 years, and, in the opinion of many experts, it remains underutilized because of a decline in health insurance reimbursements and the increase in price of UV light therapy. The market is mature but not saturated. To overcome the threats posed by competitive treatments, this market requires innovation, new marketing tactics, strategic alliances, and innovative business models. This report addresses the drivers and limiters of the market and offers an exhaustive analysis of both drugs and medical devices for use in photomedicine.

REASON FOR DOING THE STUDY
Some of the health conditions discussed in the report have very few approved treatments; in some cases, photomedicine is the only available option to the patients.
However, due to the rapid transformations occurring in research and development, new healthcare reforms, and the advent of personalized medicine, the dynamics of the
market are changing. The report analyzes the global market and includes historical sales of drugs and medical devices used in photomedicine in 2013 and estimates for
2014. Sales are forecast through 2019. This study in an invaluable instrument for understanding the pharmaceutical and medical device markets in photomedicine, as well as the need for innovation and new marketing strategies. The market is characterized by the creation of partnerships, collaborations and mergers and acquisitions (M&A) between pharmaceutical companies and the medical device industries.

SCOPE OF THE REPORT
The global market of photomedicine will grow to about $754 million by 2019 at a compound annual growth rate of 4.1% from 2014 to 2019. This report provides a detailed segmentation by region, by products and type of products, by therapeutic areas and by type of treatment. Profiles of key market players are also included. Major products that generate the largest revenues, as well as the most-valuable R&D products that will come on the market up to 2019 are provided.

In-depth competitive market analysis is discussed, with examples of how new products will enter the market or how existing products will survive or perish. The report also
includes descriptions of current and future technologies for drugs and devices used in photomedicine. In the future, nanotechnology will play a pivotal role in drug and
discovery innovation.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.